Classification and prediction of survival in patients with the leukemic phase of cutaneous T cell lymphoma

Journal of Experimental Medicine

Volumn 197, Issue 11, 2003, Pages 1477-1488

  Kari, Laszlo ^a   Loboda, Andrey ^a   Nebozhyn, Michael ^a   Rook, Alain H ^b   Vonderheid, Eric C ^c   Nichols, Calen ^a   Virok, Dezso ^a   Chang, Celia ^a   Horng, Wen Hwai ^a   Johnston, James ^a   Wysocka, Maria ^b   Showe, Michael K ^a   Showe, Louise C ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cDNA microarrays; Class prediction; CTCL; Discriminant analysis; Prognosis

Indexed keywords

BETA1 INTEGRIN; CHEMOKINE; CYTOKINE; DIPEPTIDYL PEPTIDASE IV; DUAL SPECIFICITY PHOSPHATASE 1; INTERLEUKIN 1 RECEPTOR; PROTEIN; PROTEIN PLASTIN T; PROTEOGLYCAN; PROTEOGLYCAN 2; STAT4 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CLASSIFICATION; CANCER SURVIVAL; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DISCRIMINANT ANALYSIS; DNA MICROARRAY; GENE; GENE CLUSTER; GENE DUAL SPECIFICITY PHOSPHATASE 1; GENE EXPRESSION; GENE INTERLEUKIN 1 RECEPTOR; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA; MONONUCLEAR CELL; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHOB ONCOGENE; SEZARY SYNDROME; STUDENT T TEST; T CELL LEUKEMIA;

APOPTOSIS; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; DISCRIMINANT ANALYSIS; GENE EXPRESSION PROFILING; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; SEZARY SYNDROME; SURVIVAL RATE; TH2 CELLS;

EID: 12444335268     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021726     Document Type: Article

References (53)

1. Li, G., B.R. Vowels, B.M. Benoit, A.H. Rook, and S.R. Lessin. 1996. Failure to detect human T-lymphotropic virus type-I proviral DNA in cell lines and tissues from patients with cutaneous T-cell lymphoma. J. Invest. Dermatol. 107:308-313.
2. Kim, Y.H., and R.T. Hoppe. 1999. Mycosis fungoides and the Sezary syndrome. Semin. Oncol. 26:276-289.
3. Dereure, O., P. Portales, J. Clot, and J.J. Guilhou. 2000. Decreased expression of Fas (APO-1/CD95) on peripheral blood CD4+ T lymphocytes in cutaneous T-cell lymphomas. Br. J. Dermatol. 143:1205-1210.
4. Edelson, R.L. 2001. Cutaneous T cell lymphoma: the helping hand of dendritic cells. Ann. NY Acad. Sci. 941:1-11.
5. Kim, Y.H., K. Bishop, A. Varghese, and R.T. Hoppe. 1995. Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome. Arch. Dermatol. 131:1003-1008.
6. Kim, Y.H., S. Chow, A. Varghese, and R.T. Hoppe. 1999. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides. Arch. Dermatol. 135:26-32.
7. Dummer, R., P.W. Heald, F.O. Nestle, E. Ludwig, E. Laine, S. Hemmi, and G. Burg. 1996. Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood. 88:1383-1389.
8. Nickoloff, B.J., D.P. Fivenson, S.L. Kunkel, R.M. Strieter, and L.A. Turka. 1994. Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques. Clin. Immunol. Immunopathol. 73:63-68.
9. Rook, A.H., B.R. Vowels, C. Jaworsky, A. Singh, and S.R. Lessin. 1993. The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sezary T cells. Arch. Dermatol. 129:486-489.
10. Vowels, B.R., S.R. Lessin, M. Cassin, C. Jaworsky, B. Benoit, J.T. Wolfe, and A.H. Rook. 1994. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J. Invest. Dermatol. 103:669-673.
11. Rook, A.H., K.R. Suchin, D.M. Kao, E.K. Yoo, W.H. Macey, B.J. DeNardo, P.G. Bromely, Y. Geng, J.M. Junkins-Hopkins, and S.R. Lessin. 1999. Photopheresis: clinical applications and mechanism of action. J. Investig. Dermatol. Symp. Proc. 4:85-90.
12. Gottlieb, S.L., J.T. Wolfe, F.E. Fox, B.J. DeNardo, W.H. Macey, P.G. Bromley, S.R. Lessin, and A.H. Rook. 1996. Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution. J. Am. Acad. Dermatol. 35:946-957.
13. Hastie, T., A. Buja, and R. Tibshirani. 1995. Penalized discriminant analysis. Annals of Statistics. 23:73-102.
14. Raychaudhuri, S. 2001. Penalized discriminant analysis. TIBS. 19:189-193.
15. Showe, L.C., F.E. Fox, D. Williams, K. Au, Z. Niu, and A.H. Rook. 1999. Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J. Immunol. 163:4073-4079.
16. Nakamura, T., Y. Kamogawa, K. Bottomly, and R.A. Flavell. 1997. Polarization of IL-4- and IFN-gamma-producing CD4+ T cells following activation of naive CD4+ T cells. J. Immunol. 158:1085-1094.
17. Nakamura, T., R.K. Lee, S.Y. Nam, E.R. Podack, K. Bottomly, and R.A. Flavell. 1997. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J. Immunol. 158:2648-2653.
18. Gerosa, F., C. Nisii, S. Righetti, R. Micciolo, M. Marchesini, A. Cazzadori, and G. Trinchieri. 1999. CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients. Clin. Immunol. 92:224-234.
19. Gerosa, F., C. Paganin, D. Peritt, F. Paiola, M.T. Scupoli, M. Aste-Amezaga, I. Frank, and G. Trinchieri. 1996. Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J. Exp. Med. 183:2559-2569.
20. Van Gelder, R.N., M.E. von Zastrow, A. Yool, W.C. Dement, J.D. Barchas, and J.H. Eberwine. 1990. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc. Natl. Acad. Sci. USA. 87:1663-1667.
21. Vowels, B.P., M. Cassin, E.C. Vonderheid, and A.H. Rook. 1992. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J. Invest. Dermatol. 99:90-94.
22. Eisen, M.B., P.T. Spellman, P.O. Brown, and D. Botstein. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA. 95:14863-14868.
23. Hirose, J., H. Kawashima, O. Yoshie, K. Tashiro, and M. Miyasaka. 2001. Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem. 276:5228-5234.
24. Lin, C.S., A. Lau, T. Huynh, and T.F. Lue. 1999. Differential regulation of human T-plastin gene in leukocytes and non-leukocytes: identification of the promoter, enhancer, and CpG island. DNA Cell Biol. 18:27-37.
25. Ridley, A.J. 2001. Rho proteins: linking signaling with membrane trafficking. Traffic. 2:303-310.
26. Small, J.V., K. Rottner, and I. Kaverina. 1999. Functional design in the actin cytoskeleton. Curr. Opin. Cell Biol. 11:54-60.
27. Narumiya, S., T. Ishizaki, and N. Watanabe. 1997. Rho effectors and reorganization of actin cytoskeleton. FEBS Lett. 410:68-72.
28. Bozza, M., J.L. Bliss, A.J. Dorner, and W.L. Trepicchio. 2001. Interleukin-11 modulates Th1/Th2 cytokine production from activated CD4+ T cells. J. Interferon Cytokine Res. 21:21-30.
29. Jones, D., N.H. Dang, M. Duvic, L.T. Washington, and Y.O. Huh. 2001. Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am. J. Clin. Pathol. 115:885-892.
30. Bernengo, M.G., P. Quaglino, M. Novelli, N. Cappello, G.C. Doveil, F. Lisa, A. De Matteis, M.T. Fierro, and A. Appino. 1998. Prognostic factors in Sezary syndrome: a multivariate analysis of clinical, haematological and immunological features. Ann. Oncol. 9:857-863.
31. Zipf, G. 1949. Human Behavior and Principle of Least Effort: An Introduction to Human Ecology. Addison Wesley, Cambridge, MA.
32. Gilliam, A.C., and G.S. Wood. 2000. Cutaneous lymphoid hyperplasias. Semin. Cutan. Med. Surg. 19:133-141.
33. Allison, D.B., G.L. Gadbury, M. Heo, J.R. Fernandez, C.-K. Lee, T.A. Prolla, and R. Weindruch. 2002. A mixture model approach for the analysis of microarray gene expression data. Computational Statistics and Data Analysis. 39:1-20.
34. Grogan, J.L., M. Mohrs, B. Harmon, D.A. Lacy, J.W. Sedat, and R.M. Locksley. 2001. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity. 14:205-215.
35. Rao, A., and O. Avni. 2000. Molecular aspects of T-cell differentiation. Br. Med. Bull. 56:969-984.
36. Li, B., C. Tournier, R.J. Davis, and R.A. Flavell. 1999. Regulation of IL-4 expression by the transcription factor JunB during T helper cell differentiation. EMBO J. 18:420-432.
37. Mao, X., G. Orchard, D.M. Lillington, R. Russell-Jones, B.D. Young, and S.J. Whittaker. 2003. Amplification and overexpression of JUNB is associated with primary cutaneous T-cell lymphomas. Blood. 101:1513-1519.
38. Kannagi, P. 2000. Selectins and their carbohydrate ligands in cellular recognition. Seikagaku. 72:1399-1415.
39. Pober, J.S., M.S. Kluger, and J.S. Schechner. 2001. Human endothelial cell presentation of antigen and the homing of memory/effector T cells to skin. Ann. NY Acad. Sci. 941:12-25.
40. Jaspars, L.H., R.C. Beljaards, P. Bonnet, R. Willemze, and C.J. Meijer. 1996. Distinctive adhesion pathways are involved in epitheliotropic processes at different sites. J. Pathol. 178:385-392.
41. Clissi, B., D. D'Ambrosio, J. Geginat, L. Colantonio, A. Morrot, N.W. Freshney, J. Downward, F. Sinigaglia, and R. Pardi. 2000. Chemokines fail to up-regulate beta 1 integrin-dependent adhesion in human Th2 T lymphocytes. J. Immunol. 164:3292-3300.
42. Luft, T., M. Jefford, P. Luetjens, H. Hochrein, K.A. Masterman, C. Maliszewski, K. Shortman, J. Cebon, and E. Maraskovsky. 2002. IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation. J. Immunol. 168:713-722.
43. Fraticelli, P., M. Sironi, G. Bianchi, D. D'Ambrosio, C. Albanesi, A. Stoppacciaro, M. Chieppa, P. Allavena, L. Ruco, G. Girolomoni, et al. 2001. Fractalkine (CX3CL1) as an amplification circuit of polarized Th1 responses. J. Clin. Invest. 107:1173-1181.
44. Boehme, S.A., F.M. Lio, D. Maciejewski-Lenoir, K.B. Bacon, and P.J. Conlon. 2000. The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J. Immunol. 165:397-403.
45. Perez, O.D., S. Kinoshita, Y. Hitoshi, D.G. Payan, T. Kitamura, G.P. Nolan, and J.B. Lorens. 2002. Activation of the PKB/AKT pathway by ICAM-2. Immunity. 16:51-65.
46. Namba, Y., M. Ito, Y. Zu, K. Shigesada, and K. Maruyama. 1992. Human T cell L-plastin bundles actin filaments in a calcium-dependent manner. J. Biochem. (Tokyo). 112:503-507.
47. Arpin, M., E. Friederich, M. Algrain, F. Vernel, and D. Louvard. 1994. Functional differences between L- and T-plastin isoforms. J. Cell Biol. 127:1995-2008.
48. Frucht, D.M., M. Aringer, J. Galon, C. Danning, M. Brown, S. Fan, M. Centola, C.Y. Wu, N. Yamada, H. El Gabalawy, and J.J. O'Shea. 2000. Stat4 is expressed in activated peripheral blood monocytes, dendritic cells, and macrophages at sites of Th1-mediated inflammation. J. Immunol. 164:4659-4664.
49. Fukao, T., D.M. Frucht, G. Yap, M. Gadina, J.J. O'Shea, and S. Koyasu. 2001. Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses. J. Immunol. 166:4446-4455.
50. Crul, M., G.J. de Klerk, J.H. Beijnen, and J.H. Schellens. 2001. Ras biochemistry and farnesyl transferase inhibitors: a literature survey. Anticancer Drugs. 12:163-184.
51. Prendergast, G.C. 2001. Actin' up: RhoB in cancer and apoptosis. Nat. Rev. Cancer. 1:162-168.
52. Sebti, S.M., and A.D. Hamilton. 2000. Farnesyltransferase and geranylgeranyltransferase I inhibitors in cancer therapy: important mechanistic and bench to bedside issues. Expert Opin. Investig. Drugs. 9:2767-2782.
53. Lichter, H., K. Segal, C. Mor, and R. Feinmesser. 1998. [Kimura's disease and angiolymphoid hyperplasia with eosinophilia-on disease with different expressions?]. Harefuah. 134:760-762, 832.